Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s

27 Feb 2018

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Dementia and Cognitive Impairment Research
Diet and metabolism studies
Nutritional Studies and Diet

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29487403
DOI: 10.1038/s41380-018-0030-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50sPMID 29487403Read ↗

A/T/N polygenic risk score for cognitive decline in old ageSemantic proximity Read ↗

Progress in Polygenic Composite Scores in Alzheimer’s and Other Complex DiseasesSemantic proximity Read ↗

Risk factors and predictive models in the progression from MCI to Alzheimer’s diseaseSemantic proximity Read ↗

Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's DiseaseSemantic proximity Read ↗

The Role of Genomic-Informed Risk Assessments in Predicting Dementia OutcomesSemantic proximity Read ↗

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.Semantic proximity Read ↗

Validation of newly derived polygenic risk scores for dementia in a prospective study of older individualsSemantic proximity Read ↗

The role of genomic-informed risk assessments in predicting dementia outcomes.Semantic proximity Read ↗

Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification.Semantic proximity Read ↗

A non- <i>APOE</i> Polygenic score for Alzheimer’s disease and <i>APOE-ε4</i> have independent associations with dementia in the Health and Retirement StudySemantic proximity Read ↗

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older populationSemantic proximity Read ↗

The genetic risk of Alzheimer's disease beyond APOE ε4: systematic review of Alzheimer's genetic risk scores.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.